Scott Olson/Getty ImagesNews
German conglomerate Bayer (OTCPK:BAYZF) scored a victory Friday in a trial in Arkansas in a case alleging that the company’s Roundup weedkiller caused cancer, while a similar trial in Delaware ended without a verdict.
In the Arkansas case, the plaintiffs said this Roundup, which Bayer (OTCPK:BAYRY) acquired as part of the $63 billion takeover of US agrochemical company Monsanto in 2018, caused a cancer called non-Hodgkin’s lymphoma in an Arkansas woman.
After the verdict was issued in the Arkansas State Court trial, Bayer (OTCPK: BAYZF) said the decision marked the company’s 11th legal victory in the past 17 Roundup cases.
The verdict “validates the company’s strategy of bringing cases to court based on strong scientific and regulatory evidence,” the company said, according to Bloomberg.
Earlier in the day, a Delaware Superior Court judge declared a mistrial in a separate Roundup lawsuit brought by the family of Anthony Cloud, a South Carolina landscaper who died in 2021.
After more than three days of deliberations, jurors in state court in Wilmington failed to reach an agreement on whether exposure to Roundup caused Cloud’s non-Hodgkins lymphoma.
With more than 50,000 claims pending, plaintiffs in some Roundup cases have obtained significant verdicts against Bayer (OTCPK: BAYRY) in recent months, including a $2.25 billion payout from a single suit in a Philadelphia court in January.